It is possible new templates exist for this target since these models were created.
Available Structures
12 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal structure of VEGF-A in complex with VEGFR-1 domains D1-6 |
Heteromer P15692; | 2×NAG; 19×NAG; | ||||
| Assess | ||||||
| Structural Insights into the Binding of VEGF-B by VEGFR-1D2: Recognition and Specificity |
Heteromer P49765; | 1×GOL; | ||||
| Assess | ||||||
| VEGF IN COMPLEX WITH DOMAIN 2 OF THE FLT-1 RECEPTOR |
Heteromer P15692; | |||||
| Assess | ||||||
| VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH DOMAIN 2 OF THE FLT-1 RECEPTOR |
Heteromer P15692; | |||||
| Assess | ||||||
| Crystal Structure of PlGF in Complex with Domain 2 of VEGFR1 |
Heteromer P49763; | 1×B3P; | ||||
| Assess | ||||||
| Crystal structure of human SMYD3 in complex with a VEGFR1 peptide |
Heteromer Q9H7B4; | 3×ZN; 1×SAH; 4×ACY; | ||||
| Assess | ||||||
| Crystal structure of VEGFR-1 domain 2 in presence of Zn | homo-2-mer | 2×ZN; 8×EDO; | ||||
| Assess | ||||||
| Crystal structure of VEGFR-1 domain 2 in presence of Cobalt | homo-2-mer | 3×CO; 3×EDO; | ||||
| Assess | ||||||
| Crystal structure of VEGFR1 in complex with N-(4-Chlorophenyl)-2-((pyridin-4-ylmethyl)amino)benzami… | monomer | 1×8ST; 1×CL; | ||||
| Assess | ||||||
| THE VEGF-BINDING DOMAIN OF FLT-1, 20 NMR STRUCTURES | monomer | |||||
| Assess | ||||||
| THE VEGF-BINDING DOMAIN OF FLT-1 (MINIMIZED MEAN) | monomer | |||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF VEGFR-1 DOMAIN 2 IN PRESENCE OF CU | monomer | 1×NA; 1×SO4; | ||||
| Assess | ||||||
3 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 3vhe.1.A | monomer | 0.69 | 73.88 | |||
| Assess | ||||||
| 5t89.1.C | monomer | 0.66 | 100.00 | |||
| Assess | ||||||
| 7lbf.1.D | monomer | 0.52 | 32.05 | |||
| Assess | ||||||
7 SWISS-MODEL models built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 5t89.1.D | monomer | 0.78 | 100.00 | ||
| Assess | ||||||
| Isoform 3 | 5t89.1.D | monomer | 0.78 | 100.00 | ||
| Assess | ||||||
| Isoform 4 | 5t89.1.D | monomer | 0.73 | 99.80 | ||
| Assess | ||||||
| Isoform 5 | 3hng.1.A | monomer | 0.70 | 1×8ST; | 100.00 | |
| Assess | ||||||
| Isoform 6 | 3vhe.1.A | monomer | 0.68 | 72.13 | ||
| Assess | ||||||
| Isoform 7 | 3wze.1.A | monomer | 0.81 | 79.53 | ||
| Assess | ||||||
| Isoform 8 | 3wze.1.A | monomer | 0.79 | 76.50 | ||
| Assess | ||||||